Article

Progression of Parkinson's disease as evaluated by Hoehn and Yahr stage transition times.

Department of Pharmacy, National University of Singapore, Republic of Singapore.
Movement Disorders (impact factor: 4.51). 03/2010; 25(6):710-6. DOI:10.1002/mds.22875
Source: PubMed

ABSTRACT This study was carried out to evaluate progression in Parkinson's disease (PD) by analyzing time taken to transit from one Hoehn and Yahr (H&Y) stage to the next stage and to investigate the variables that would be associated with H&Y transition times using a large PD database that contained prospectively collected information. Data were obtained from the movement disorder database of the National Neuroscience Institute in Singapore. Kaplan-Meier (KM) survival analysis was adopted to investigate the time taken to progress through various H&Y stages. Cox regression analysis was used to examine the association between the baseline variables at the entry point of each H&Y stage and the progression to the next stage. A total of 695 patients (mean age: 65.2, male: 57.3%) were studied. Using KM analysis, the median time taken to transit from H&Y stage 1 to 2, 2 to 2.5, 2.5 to 3 were 20, 62, and 25 months, respectively; whereas the median time taken to progress from stage 3 to 4 and 4 to 5 were 24 and 26 months, respectively. Cox regression analysis revealed that older age-at-diagnosis, longer PD duration, and higher Unified Parkinson's Disease Rating Scale (UPDRS) motor scores at baseline were associated with a significantly faster progression through various H&Y stages. Gender and ethnicity were not associated with disease progression. In conclusion, H&Y transition time is a useful measure of disease progression in PD and may be utilized in clinical studies evaluating therapeutic interventions and prognostic factors in PD.

0 0
 · 
0 Bookmarks
 · 
43 Views

Keywords

25 months
 
26 months
 
baseline variables
 
Cox regression analysis
 
disease progression
 
H&Y stage
 
H&Y stage 1
 
H&Y transition time
 
H&Y transition times
 
higher Unified Parkinson's Disease Rating Scale
 
large PD database
 
median time
 
movement disorder database
 
National Neuroscience Institute
 
older age-at-diagnosis
 
Parkinson's disease
 
PD duration
 
therapeutic interventions
 
useful measure
 
various H&Y stages